CORE LABS INC (CLB)
(Delayed Data from NYSE)
$19.31 USD
+0.41 (2.17%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $19.34 +0.03 (0.16%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.31 USD
+0.41 (2.17%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $19.34 +0.03 (0.16%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
Zacks News
Halliburton (HAL) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Halliburton (HAL) delivered earnings and revenue surprises of 2.67% and 0.84%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Oceaneering International (OII) Soars 13.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Oceaneering International (OII) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Implied Volatility Surging for Core Laboratories (CLB) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Core Laboratories (CLB) stock based on the movements in the options market lately.
Core Laboratories (CLB) Up 1.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Labs (CLB) Q1 Earnings & Sales Beat Estimates
by Zacks Equity Research
Core Labs (CLB) expects second-quarter 2023 revenues of $130-$135 million, earnings of 20-24 cents per share and operating income of $14.5-$17.5 million.
Core Laboratories (CLB) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 11.76% and 1.66%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Oil & Gas Service Firms Hit by Stalling Activity Levels in Q1
by Turjya Saha
Halliburton (HAL), Core Labs (CLB) and Schlumberger Ltd. (SLB) are likely to have been impacted by poor sentiment, rising costs, and weak prices in Q1. These factors might impact profitability & rising break-even prices.
Core Laboratories (CLB) Up 0.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Laboratories (CLB) Q4 Earnings Beat, Revenues Miss
by Zacks Equity Research
Core Labs' (CLB) revenues for the first quarter of 2023 are anticipated in the $125-$129 million range, while the operating income is estimated in the $11.5-$14.5 million band.
Core Laboratories (CLB) Surpasses Q4 Earnings Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 5.26% and 1.83%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Core Laboratories (CLB) Q4 Earnings Expected to Decline
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Core Labs (CLB) Reveals Plans to Transfer Domicile to U.S.
by Zacks Equity Research
Core Labs plans to relocate from the Netherlands to the United States to increase shareholder value over time by streamlining its corporate structure, enhancing operational effectiveness and reducing cost.
SLB or CLB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SLB vs. CLB: Which Stock Is the Better Value Option?
Core Laboratories (CLB) Up 9.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
SLB vs. CLB: Which Stock Is the Better Value Option?
by Zacks Equity Research
SLB vs. CLB: Which Stock Is the Better Value Option?
Core Labs (CLB) Q3 Earnings Surpass Estimates, Sales Meet
by Zacks Equity Research
Core Labs' (CLB) third-quarter earnings beat the consensus mark, while revenues meet the same.
Eni (E) Scheduled to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Higher commodity prices are likely to have been favorable for Eni's (E) exploration and production operations in Q3.
Pioneer Natural (PXD) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Lower production is expected to have affected Pioneer Natural's (PXD) earnings in Q3.
Schlumberger (SLB) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Schlumberger (SLB) delivered earnings and revenue surprises of 14.55% and 4.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Linde (LIN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Linde (LIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is a Beat in the Offing for EQT Corp's (EQT) Q3 Earnings?
by Zacks Equity Research
Higher sales volumes and commodity prices are likely to have aided EQT Corp's (EQT) earnings in Q3.
Core Laboratories (CLB) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Core Laboratories (CLB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SLB or CLB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SLB vs. CLB: Which Stock Is the Better Value Option?
SLB or CLB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SLB vs. CLB: Which Stock Is the Better Value Option?
SLB vs. CLB: Which Stock Is the Better Value Option?
by Zacks Equity Research
SLB vs. CLB: Which Stock Is the Better Value Option?